HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 170 filers reported holding HAEMONETICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $166,324,000 | +27.0% | 4,137,423 | +14.4% | 0.03% | +14.8% |
Q3 2016 | $130,959,000 | +35.6% | 3,616,662 | +8.6% | 0.03% | +28.6% |
Q2 2016 | $96,588,000 | -14.7% | 3,331,768 | +2.9% | 0.02% | -19.2% |
Q1 2016 | $113,218,000 | +8.5% | 3,236,644 | -0.0% | 0.03% | +8.3% |
Q4 2015 | $104,395,000 | +5.5% | 3,238,043 | +5.8% | 0.02% | -7.7% |
Q3 2015 | $98,946,000 | -20.8% | 3,061,460 | +1.4% | 0.03% | -13.3% |
Q2 2015 | $124,899,000 | -9.0% | 3,019,800 | -1.1% | 0.03% | -9.1% |
Q1 2015 | $137,227,000 | +26.7% | 3,054,927 | +5.5% | 0.03% | +22.2% |
Q4 2014 | $108,312,000 | +17.3% | 2,894,502 | +9.5% | 0.03% | +3.8% |
Q3 2014 | $92,315,000 | -4.1% | 2,643,620 | -3.1% | 0.03% | -3.7% |
Q2 2014 | $96,255,000 | +2.1% | 2,728,327 | -5.7% | 0.03% | -3.6% |
Q1 2014 | $94,267,000 | -21.1% | 2,892,523 | +2.0% | 0.03% | -22.2% |
Q4 2013 | $119,525,000 | +8.4% | 2,837,060 | +2.6% | 0.04% | -2.7% |
Q3 2013 | $110,298,000 | +8.9% | 2,765,748 | +13.0% | 0.04% | 0.0% |
Q2 2013 | $101,247,000 | – | 2,448,534 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |